Acuitas Therapeutics Named One of Canada’s Top Small & Medium Employers of 2024

On top of the recent naming of Acuitas Therapeutics, Inc. as one of BC’s Top Employers of 2024, the organization was just named one of Canada’s Top Small & Medium Employers of 2024. The Vancouver-based, privately held biotechnology firm is the global leader in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticles.

“We are honoured to be named as one of Canada’s Top Small & Medium Employers,” said President & CEO Dr. Thomas Madden. He added: “We have some of the world’s best scientists and business professionals on our team, and we are dedicated to the transformative power of science – in our case, biotechnology – to improve lives. Our scientific innovation attracts exceptional talent, and our culture of innovation and collaboration retains them. It is a great combination. From the moment when we opened Acuitas, a priority has been to develop and maintain a positive company culture and everyone on the team is committed to this. We have a culture where everyone feels respected, heard and valued – and where we have fun together. This, to me, is an exceptional achievement and credit belongs to the entire Acuitas team.”